Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 2:30 AM
Study NCT ID:
NCT07357051
Status:
RECRUITING
Last Update Posted:
2026-01-21
First Post:
2026-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
Sponsor:
Joincare Pharmaceutical Group Industry Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-08
First Submit QC Date:
None
Study First Post Date:
2026-01-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-15
Last Update Post Date:
2026-01-21
Last Update Post Date Type:
ACTUAL